Skip to main content

Ragan Paula

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Ragan Paula as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

XFOR X4 Pharmaceuticals, Inc

President and CEO19 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 16, 2021 (view filing)Jul 151 dayRagan PaulaPresident and CEOSSale−13.4K$5.78−$77.7K−2.7%482.5K after
Aug 19, 2021 (view filing)Aug 172 daysRagan PaulaPresident and CEOSSale−13.4K$5.10−$68.6K−2.8%469.0K after
Feb 14, 2022 (view filing)Feb 113 daysRagan PaulaPresident and CEOSSale−21.7K––−4.6%447.3K after
Jun 6, 2022 (view filing)Jun 33 daysRagan PaulaPresident and CEOSSale−6.29K$1.21−$7.61K−0.9%661.8K after
Jun 17, 2022 (view filing)Jun 161 dayRagan PaulaPresident and CEOSSale−6.72K––−1.0%655.1K after
Jun 27, 2022 (view filing)Jun 243 daysRagan PaulaPresident and CEOSSale−6.72K––−1.0%648.4K after
Aug 19, 2022 (view filing)Aug 172 daysRagan PaulaPresident and CEOSSale−13.4K––−2.1%634.9K after
Feb 15, 2023 (view filing)Feb 132 daysRagan PaulaPresident and CEOSSale−21.7K$0.93−$20.2K−3.4%613.2K after
Mar 13, 2023 (view filing)Mar 103 daysRagan PaulaPresident and CEOSSale−49.7K$0.84−$41.7K−8.1%563.5K after
May 31, 2023 (view filing)May 31Same dayRagan PaulaPresident and CEOSSale−6.29K$1.95−$12.3K−1.1%557.2K after

See all 19 trades at XFOR